NASDAQ:CPIX
Cumberland Pharmaceuticals Inc. Stock News
$1.53
-0.0500 (-3.16%)
At Close: May 06, 2024
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
12:03pm, Wednesday, 11'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Aytu
Earnings Preview: Cumberland Pharmaceuticals (CPIX) Q4 Earnings Expected to Decline
12:00am, Wednesday, 11'th Mar 2020The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
08:14pm, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.
The week was light on news flow, barring some smid-cap earnings and...
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
12:00am, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.
The week was light on news flow, barring some smid-cap earnings and...
Cumberland Pharmaceuticals Reschedules Fourth Quarter And Annual 2019 Financial Results
09:35pm, Friday, 06'th Mar 2020
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today the rescheduling of its fourth quarter and annual 2019 financial results and company update from Wednesday, March 11, 2020 to Wednesday,
Cumberland Pharmaceuticals Reschedules Fourth Quarter And Annual 2019 Financial Results To Wed. Mar. 18 After The Close
12:00am, Friday, 06'th Mar 2020Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2019 Financial Results
02:35pm, Wednesday, 04'th Mar 2020
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release fourth quarter and annual 2019 financial results and company update after the market closes on Wednesday, March 11,
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
12:28pm, Friday, 28'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on Feb. 27)
Global Cord Blood Corp (...
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 26.) Co-Diagnostics Inc (NASDAQ: CODX ) Fat
Analysts' Top Conglomerates Picks: Intricon (IIN), Aspen Aerogels (ASPN)
12:45pm, Tuesday, 25'th Feb 2020
There's a lot to be optimistic about in the Conglomerates sector as 2 analysts just weighed in on Intricon (IIN) and Aspen Aerogels (ASPN) with bullish
Edited Transcript of TBPH earnings conference call or presentation 24-Feb-20 10:00pm GMT
07:06am, Tuesday, 25'th Feb 2020
Q4 2019 Theravance Biopharma Inc Earnings Call
Viewray (VRAY) Receives a Hold from B.Riley FBR
12:41pm, Thursday, 06'th Feb 2020
In a report released today, Andrew D'silva from B.Riley FBR assigned a Hold rating to Viewray (VRAY), with a price target of $5.00. The company's shares
Viewray (VRAY) Receives a Hold from B.Riley FBR
12:41pm, Thursday, 06'th Feb 2020
In a report released today, Andrew D’silva from B.Riley FBR assigned a Hold rating to Viewray (VRAY – Research Report),
3 “Strong Buy” Biotech Stocks That Can Inject a Healthy Dose of Upside
02:13pm, Sunday, 19'th Jan 2020
Biotech stocks require only a few select indicators to send a share price soaring, or conversely, to cause it to tumble mercilessly down the charts. An FDA decision or results from a clinical trial ha
